Management of adjuvant settings for Stage III melanoma patients in France prior to checkpoint inhibitors: epidemiological data from the RIC-Mel database.
Fiche publication
Date publication
août 2020
Journal
European journal of dermatology : EJD
Auteurs
Lien Pubmed
Résumé
Targeted therapies such as BRAF and MEK inhibitors and immunotherapies have been made available to treat melanoma.
Mots clés
BRAF, adjuvant treatment, immunotherapy, melanoma, sentinel lymph node, targeted treatment
Référence
Eur J Dermatol. 2020 Aug 19;: